Abstract
Behavioral aspects and underlying pathology of attention deficit in multiple sclerosis (MS) remain unknown. This study aimed to clarify impairment of attention and its relationship with MS-related fatigue. Thirty-four relapse-remitting MS (RRMS), 35 secondary-progressive MS (SPMS) and 45 healthy controls (HC) were included. Results of psychophysics tasks (attention network test (ANT) and Posner spatial cueing test) and fatigue assessments (visual analogue scale and modified fatigue impact scale (MFIS)) were compared between groups. In ANT, attentional network effects were not different between MS phenotypes and HC. In Posner task, RRMS or SPMS patients did not benefit from valid cues unlike HC. RRMS and SPMS patients had less gain in exogenous trials with 62.5 ms cue-target interval time (CTIT) and endogenous trials with 250 ms CTIT, respectively. Total MFIS was the predictor of gain in 250 ms endogenous blocks and cognitive MFIS predicted orienting attentional effect. Executive attentional effect in RRMS patients with shorter disease duration and orienting attentional effect in longer diagnosed SPMS were correlated with MFIS scores. The pattern of attention deficit in MS differs between phenotypes. Exogenous attention is impaired in RRMS patients while SPMS patients have deficit in endogenous attention. Fatigue trait predicts impairment of endogenous and orienting attention in MS.
Similar content being viewed by others
Introduction
Multiple sclerosis (MS) is the primary cause of non-traumatic disability in young adults1. Two-third of MS patients suffer from cognitive impairment which reduces their quality of personal, social, and professional life2. Although there is increasing evidence for the importance of cognitive comorbidities in MS, consensus on appropriate objective assessment and treatment has not been reached so far3 and the course of these comorbidities can only be poorly predicted4,5,6. Attention, the process through which the brain selects information for further processing7,8, is one of the main affected cognitive domains in adults with MS9. Their common complaints are about switching attention and keeping up with a specific stimulus when there are distractors nearby10. Moreover, attention is also frequently impaired in pediatric MS patients11,12,13.
Various factors can affect attention of MS patients. Both neuropsychological and psychophysics studies have highlighted the role of disease phenotype in impairment of attention; Some studies have shown more frequent and severe difficulties in progressive forms of the disease, while others point to contrary findings14,15,16. However, patterns of attention deficit in different MS phenotypes have not been studied in details.
MS-related fatigue has been also suggested as a possible effective factor on attention17,18. Fatigue is the most common and debilitating symptom in MS patients19 and has been shown to correlate with changes in brain networks e.g., salience network, which are responsible for attentional processes20. Moreover, attention tests have been proposed as a valid measure of cognitive fatigue in MS21,22. However, the results regarding this relationship are inconsistent; As reviewed by Golan et al., Some studies have found a negative correlation between fatigue and attention, while in others no association was observed after considering cofounding variables23. Conflicting findings and unclear pathophysiology of these conditions in MS24 highlight the need for further evaluation.
Most studies have used neuropsychological tests to assess attention of MS patients2,25,26. These tests only give a general evaluation of attention without distinguishing between different forms of impairment, which can partly explain the inconsistency of previous results. On the other hand, psychophysics tasks enable a straightforward detailed assessment of attention with minimal influence from other cognitive domains. Also, different psychophysics tasks can engage different forms of attention, which can be used to categorize attentional impairment.
Gonzalez-Rosa et al., were the first group applying an attention psychophysics task—Posner spatial cueing test27—in MS patients. In addition to poorer task performance in the patient group, those with benign form of the disease showed higher attentional deterioration than relapse-remitting MS (RRMS)16,28. Later on, Urbanek et al., conducted attention network test (ANT) in MS patients29. They found a significant lower alerting effect in RRMS patients compared to healthy control (HC) and no differences in orienting and executive effects30. In ANT, each network carries out a function similar to its name; Alerting network achieves and maintains alert state, orienting network selects information from sensory input, and executive network resolves conflict among responses. Although stability and reliability of ANT results were shown across time in RRMS patients, attentional network deficits were not similarly reproduced31,32,33,34. Roth et al., recruited secondary progressive MS (SPMS) as well as RRMS and applied ANT. They analyzed the data from different perspectives and found that the attentional deficit was confined to alerting network and only in SPMS patients35. Among psychophysics studies of attention in MS, only a few have evaluated different disease phenotypes and no study has investigated the role of fatigue.
In this study, we applied 2 psychophysics tasks i.e., ANT and Posner spatial cueing test, in order to provide a clearer picture of attentional impairment in RRMS and SPMS phenotypes of MS. As far as we know, this is also the first study to investigate the relationship between MS-related fatigue and attention in more details by measuring separately the trait and the state of fatigue and evaluating attention using psychophysics tasks.
Materials and methods
Participants
Sixty-nine MS patients (34 with RRMS and 35 with SPMS phenotype) of MS day clinic at Kashani Hospital, Isfahan, Iran, who had following criteria, were recruited in a full-census manner: had been diagnosed based on McDonald criteria 201736; were between 18 to 55 years old; had been diagnosed longer than 5 and shorter than 15 years; had no history of acute clinical relapse or treatment with corticosteroids in the last 2 months; had normal or corrected-to-normal vision; performed 9-hole peg test (9-HPT) in less than 45 s for each hand37; did not have any history of brain surgeries, major neurologic and psychiatric disorders (stroke, epilepsy, brain tumor, central nervous system infection, major depressive disorder, bipolar disorder, schizophrenia, and substance abuse), chronic systemic disorders (diabetes, renal failure, liver failure, and chronic obstructive pulmonary disease), possible causes of fatigue (anemia, hypothyroidism, hyperthyroidism, vitamin-D deficiency, and sleep disorders), and taking medications that possibly affect cognition (antiepileptics, antidepressants, antipsychotics, and antihistamines). An increased impairment in one functional system score to 3 or in total EDSS score to 1.5 was considered as significant disability. Confirmed progression in SPMS patients was defined as sustained significant disability for at least 6 months. Results of 9-HPT of dominant hand based on seconds were adjusted for age and gender according to the recently published norms for further analysis38. Forty-five HC who were demographically comparable to the patient group and had no first-degree relatives diagnosed with MS were included as well.
Procedure
Subjects sat in front of a 15″ cathode ray tube monitor at ~ 48 cm distance to perform psychophysics tasks, after the instructions were given to them written and verbally. Persian version of modified fatigue impact scale (MFIS) and Montreal cognitive assessment (MoCA) test were also taken from subjects. MFIS questionnaire has 21 items, concerning the frequency of fatigue experienced in the past 4 weeks (trait of fatigue), and gives a total score and three subscores of physical, cognitive, and psychosocial39. MoCA test is a 30-point cognitive screening tool evaluating attention, memory, visuospatial abilities, executive function, language, and orientation that gives a total score40.
Psychophysics tasks
ANT and Posner spatial cueing test29,41 were designed in MATLAB version R2016a (MathWorks Inc., Natick, Massachusetts, USA) using PsychToolbox extension-342,43. Before and after each of the six blocks of the tasks, a 10 cm line marked by numbers from 0 to 100 in steps of 25, visual analogue scale (VAS)44, was shown to the participant to select a score for the level of fatigue experienced at that moment (state of fatigue) by clicking on the desired number. Mean VAS score was computed as the average of all reported VAS scores through each task. Out of all subjects, 34 patients (16 RRMS, 18 SPMS) and 12 HC participated in both psychophysics tasks.
ANT
Each block consisted of 48 randomly-presented trials (4 cue types × 6 target types × 2 target positions). Subjects were asked to keep fixation throughout the trials. One of four types of cues was presented on each trial (Fig. 1). No cue was the continuation of displaying the fixation cross for assessing the state of non-alertness, whereas central cue, was an asterisk with similar size and position with fixation cross to alert the subject. Double cue were two asterisks, 1° above and below the fixation cross, to partially orient the subject besides alerting them. Spatial cue was an asterisk 1° above or below the fixation cross that completely assessed the state of alerting and spatial orienting of the participant. After a 400 ms delay, one of six following types of 3° targets was presented at the position of spatial cue. Target was consisted of a right or left directed arrow at the center and two lines or arrows on the right and left sides of the central one (line or arrow length: 0.55°, separation distance: 0.06°). The first (and second) neutral target had 4 flanker lines and a right (and left) directed arrow at the center. The third and fourth type had 5 similar rightward or leftward arrows called congruent targets. The last two incongruent ones had 4 flanker arrows with the opposite direction relative to the central arrow. The subject had to press the right or left arrow key on the keyboard to report the direction of central arrow as soon as possible.
Posner spatial cueing test
Each trial of this task began with presenting a fixation point and subjects were asked to keep fixation throughout the task (Fig. 2). Target was a solid black square presented at 7° right or left of the fixation point. Subject had to press the right or left arrow key on the keyboard as soon as the target was seen. In the first three blocks to assess exogenous attention, cue was an empty black square (size = 10°) presented at the same location as the target in 80% of non-neutrally cued trials (valid trials), or on the opposite site of the fixation point compared to the following target in the remaining 20% of the trials (invalid trials). In the last 3 blocks, the cue was a right or left directed arrow (size = 10°) at the center of screen to evaluate endogenous attention. A plus sign (size = 10°) presented at the position of fixation point acted as a neutral cue in both types of exogenous and endogenous tasks, where the probability of target presentation on the right or left side was 50%. Out of 70 trials in each block, 25 (and 25) trials had right (and left) directed arrow or right-sided (left-sided) empty square, and the remaining 20 trials had plus sign as the neutral cue. Cue-target interval times (CTIT, 0, 62.5, 125, 250, or 500 ms) were presented equally in each block in a random order.
In both tasks, the time from target presentation to key press by subject was defined as reaction time (RT) which was only reported for correct trials. Error rate (ER) was defined as the percent of wrong responses to the sum of wrong and correct responses.
Statistical analysis
Statistical analysis was performed using MATLAB version R2021b. Whenever data did not follow the normal distribution (tested by Anderson–Darling test), Kruskal–Wallis test with Tukey Kramer post hoc and Spearman correlation were used for comparing groups and evaluating associations, respectively. Comparing proportions were done by applying χ2 test of independence. Hierarchical regression was performed using generalized linear model with gamma or normal distribution and canonical link to determine effects, interactions, and predictive variables. Moreover, area under receiver operating curve (ROC) was measured for evaluation of discriminatory capacity. Significance level was 0.05 in all tests.
Ethics approval
This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Isfahan University of Medical Sciences, Isfahan, Iran (Ethics committee code: IR.MUI.MED.REC.1400.229).
Informed consent
Informed consent was obtained from all included subjects prior to their participation in the study.
Results
ANT
Demographic and clinical characteristics of participants of this task are summarized in Table 1 in addition to disease modifying drugs (DMD) of patients which are found in Supplementary Table S1. RT and ER of participants are shown for each group in Fig. 3. Total RT was significantly longer in SPMS patients compared to HC (χ2 = 9.3, p < 0.007). Unlike ER, almost all cue-target specific RTs were also significantly longer in SPMS group versus HC (Supplementary Table S2). By assessing the effect of group on RT or ER separately and with consideration of clinical characteristics, group showed significant effect on RT (t = − 3.4, p < 0.002). Also, RT of incongruent trials were longer than neutral trials (t = − 4.5, p < 0.001), and ER was higher in incongruent compared to neutral trials (t = 2.6, p < 0.009) in all groups. In HC age had significant effect on RT (t = − 6.6, p < 0.001); however, different cues, disease duration, EDSS, or 9-HPT had no effect on either RT or ER in all groups (p > 0.06).
Calculation of attentional network effects was based on previous studies29,30,31. Differential alerting effect is the subtraction of mean RT of trials with double cue from trials with no cue, while differential orienting effect is the difference between mean RT of trials with spatial cue and center cue. Differential executive effect is measured by subtracting the mean RT of congruent trials from incongruent ones (Fig. 4A). Proportional effects (Fig. 4B) are differential effects divided by mean RT of all trials, and residual effects (Fig. 4C) are differential effects adjusted by mean RT of trials with no cue and neutral targets using linear regression model. Differential, proportional, and residual attentional network effects, including alerting, orienting, and executive, were not statistically different between groups (p > 0.1) (Supplementary Table S3).
By evaluating the association of MFIS scores and attentional network effects, differential executive effect was found to be positively correlated with MFIS scores in RRMS (not SPMS) patients (Fig. 5). Proportional or residual executive effects also showed the same trend (r = 0.3, p < 0.05). Moreover, when RRMS and SPMS patients were divided to 2 groups separately based on the median of disease duration, EDSS, or 9-HPT in each phenotype, shorter diagnosed RRMS patients showed the previously mentioned positive correlation between executive attentional effect and MFIS scores (r = 0.6, p < 0.03). Also, a negative correlation was found in longer diagnosed SPMS patients between orienting attentional effect and MFIS scores (r = − 0.6, p < 0.04). By EDSS analysis, a significant positive correlation was observed in RRMS patients with more severe disability between executive attention and total, physical, and cognitive MFIS scores (r = 0.6, p < 0.05). Same trend was also shown by 9-HPT analysis in RRMS patients with weaker hand function between executive attention and total and physical MFIS scores (r = 0.6, p < 0.05).
To assess predictors of attentional network effects, we considered group (RRMS and SPMS), MFIS (total and cognitive, separately) or VAS scores, disease duration, and 9-HPT or EDSS score consecutively in hierarchical regression analyses. At the level of adding disease duration to predictors of differential executive effect (group and cognitive MFIS score), group showed significant main effect (t = 2.2, p < 0.04) and significant interaction with disease duration (t = − 2, p < 0.05). For differential orienting effect, at the level of adding cognitive MFIS score to group, the main effect of cognitive MFIS (t = 2.8, p < 0.008) and its interaction with group (t = − 2.5, p < 0.02) were statistically significant. Regression analyses using total MFIS, VAS, or 9-HPT revealed no significant predictive effect.
Posner spatial cueing test
Demographic and clinical characteristics of participants of this task are summarized in Table 2 in addition to DMDs of patients which are found in Supplementary Table S1. RT and ER of participants are shown for both exogenous and endogenous tasks in Supplementary Figs. S1 and S2. Only ER at 125 ms (χ2 = 9.1, p < 0.01) and 500 ms (χ2 = 6.6, p < 0.04) CTIT were significantly higher in SPMS versus RRMS patients in the exogenous task. Classifying trials by type of the cue or CTIT, showed that trials with 500 ms CTIT were significantly shorter than trials with 0 ms CTIT in all groups (p < 0.02). In addition, valid trials were significantly shorter than invalid trials in both endogenous (χ2 = 9.9, p < 0.002) and exogenous (χ2 = 6.3, p < 0.02) tasks in HC, while this was not observed in RRMS or SPMS patients (p > 0.07).
We defined gain as the difference between mean RT of valid trials and neutral trials (smaller the number, higher the gain), and cost as the mean RT of invalid trials subtracted by neutral trials (smaller the number, lower the cost). Gain and cost, averaged over all trials of endogenous or exogenous tasks, were statistically similar between groups (p > 0.1). However, taking CTIT into account (Fig. 6), revealed that RRMS patients had less gain in 62.5 ms CTIT in the exogenous task (χ2 = 6, p < 0.05) and SPMS patients had less gain in 250 ms in the endogenous task (χ2 = 6.9, p < 0.04), compared to HC (Supplementary Table S4). By plotting ROC curve and calculating area under curve (AUC) for gain in 62.5 ms CTIT in exogenous task (0.6738) and 250 ms CTIT in endogenous task (0.6015), acceptable ability of these two measures to discriminate RRMS from SPMS phenotype was shown (Supplementary Fig. S3).
Evaluating the association between gain of 250 ms in the endogenous task and clinical characteristics, significant correlation was observed in SPMS patients with EDSS (r = 0.5, p < 0.04) and 9-HPT (r = − 0.5, p < 0.05). We did not find any significant relationship for gain of 62.5 ms in the exogenous task.
Hierarchical regression analyses were applied to determine predictive variables for endogenous (at 250 ms CTIT) or exogenous (at 62.5 ms CTIT) gain. Group (RRMS and SPMS), MFIS (total and cognitive, separately) or VAS scores, disease duration, and 9-HPT or EDSS score were considered in this order. When the dependent variable was gain at 250 ms in the endogenous task, and predictors were group, total MFIS score, disease duration, and EDSS, total MFIS showed significant main effect (t = − 2.2, p < 0.04) as well as an interaction with EDSS (t = 2.1, p < 0.05). Replacing total MFIS with VAS or cognitive MFIS, EDSS with 9-HPT, or using gain at 62.5 ms in exogenous task as the dependent variable did not lead to any significant effect.
Discussion
In ANT, SPMS patients reacted to each type of cues and targets slower than HC albeit with comparable number of correct responses and differences between trials because of the presence of distractors. This was not the case for RRMS patients, which raises the question of whether poorer performance of SPMS could be due to more severe disability or longer disease duration versus RRMS. However, disability—measured by EDSS and 9-HPT—and disease duration had no effect on RT or ER. This observation was in line with previous studies, in which more severe cognitive impairment was still remarkable in MS patients with progressive forms of disease after considering their disability status and duration of disease14.
Regarding attention of MS patients, some previous psychophysics studies also have reported longer RT than HC that might not accompany higher ER30,33,34, tough only Roth et al., have enrolled SPMS phenotype35. They observed general slowing as well as more false responses in SPMS compared to HC. In addition, they were the only group who applied all three methods of measuring attentional networks (differential, proportional, and residual) and found out alerting impairment in SPMS patients. According to our results, no matter which method for measurement was used, RRMS and SPMS phenotypes did not differ from HC in their ability to alert, orient, and execute in presence of distractors in environment. This difference could be explained by the larger and more homogenous sample population in our study which did not include patients at both ends of the spectrum of disease duration and in turn disability.
In Posner spatial cuing test, although performance regarding RT or ER was not poorer in MS patients, neither RRMS nor SPMS benefited from valid cues in contrast to HC. Gonzalez et al., the only previous group that studied attention in MS with Posner paradigm, found that benign forms of disease did not show validity effect (RT of valid trials subtracted by RT of invalid trials41) probably due to a divided attention condition instead of an oriented spatial attention16. We extended their finding to a broader spectrum of MS including both RRMS and SPMS phenotypes. Also, we divided validity effect into gain and cost mathematically and did not find any difference in gain or cost between groups, which was at odd with what was observed about validity effect. To investigate this matter further, we looked at cost and gain at different CTITs.
For the first time to best of our knowledge, in this study, endogenous and exogenous spatial attention were studied separately in each patient with MS. In case of a voluntary goal, endogenous attention, and in the presence of an unexpected external stimulus in environment, exogenous attention is deployed45. Previous experiments have shown that exogenous attention is deployed in windows shorter than 100 ms, while endogenous attention come into use around 300 ms46. In our study, 62.5 ms and 250 ms CTIT in Posner spatial cuing test represent almost the peak effects of exogenous and endogenous attention, respectively.
The pattern of attention deficit differs from RRMS to SPMS phenotype. Comparing gain and cost between groups by considering CTIT, and the AUC for gain in 62.5 ms in exogenous and 250 ms in endogenous task, revealed that Posner spatial cueing test can differentiate RRMS from SPMS phenotype. Exogenous attention is impaired in RRMS patients, while SPMS patients have deficit in endogenous attention. That might be one of the reasons why we did not observe validity effect in neither of MS phenotypes. Current evidences suggest that endogenous and exogenous spatial attention have distinct neural basis besides different behavioral effects47,48, e.g., dorsal fronto-parietal regions and frontal to parietal direction of connectivity modulation are engaged in endogenous attention, while more ventral fronto-parietal network and preceding parietal activity have been observed in exogenous attention49. Along the course of MS from early to late stages, brain pathologies vary from focal white matter to more cortical and diffuse demyelinating lesions50. Thus, distinct neural substrates of endogenous and exogenous attention might link to distinguishable brain pathologies of RRMS and SPMS, waiting for further studies for its evaluation. As reviewed by Brochet et al., few previous studies have compared cognitive impairment between RRMS and SPMS patients using neuropsychological tests14, which have mostly reported more frequent and more severe attentional impairment in SPMS compared to RRMS. However, the patterns or mechanisms underlying cognitive differences between RRMS and SPMS phenotypes have not been studied in detail.
Our results also support the idea that two aspects of disease progression in MS (physical and cognitive) could interact with each other51; As SPMS patients with more severe disability had more impaired endogenous attention. This was shown not only by the EDSS score but also by the 9-HPT, which might be a better indicator of disability in psychophysics studies that are dependent on hand function.
The relationship between trait of fatigue and cognition in MS has been previously studied17,52,53,54,55. Findings regarding this relationship are inconsistent, such that only some studies suggest an association between the level of fatigue and impairment in cognitive domains including attention. Moreover, it has been shown that the interplay between fatigue and cognition is not completely independent of other clinical features such as comorbidities23.
In this study in RRMS patients, cognitive fatigue could predict better performance in orienting attention, whereas in SPMS, particularly longer diagnosed patients, cognitive fatigue was negatively correlated with orienting attention. This result can be partly explained by the dual regulation system of fatigue in MS patients56. According to Ishii et al., fatigue can activate an inhibitory response during challenging tasks. In the meantime, an increased brain activation compensates for inhibitory effects of fatigue to ensure cognitive performance, as seen in RRMS patients. However, when brain damages are too great, as in progressive forms of disease, this compensatory response may be insufficient and the inhibitory effect of fatigue prevails57.
As another result, cognitive fatigue was negatively correlated with the ability to maintain attention in presence of distractors and conflicting information only in RRMS patients. This could be justified by previous studies which have suggested executive failure as the main characteristic of cognitive fatigue58,59. The reason why this was not seen in SPMS patients, could be the different pathophysiological factors that are associated with fatigue in different phenotypes of MS, suggested in previous studies60,61.
How fatigue affects attention has not been widely studied. Few clues have been obtained through neuroimaging studies which assessed attention and fatigue simultaneously. Thalamic subregions, hippocampus, and supramarginal area have been shown to be in relation with both fatigue and attention in MS patients62,63,64. Also, similar brain changes underlying attention deficit and MS-related fatigue have been revealed separately, such as structural changes in cortico-striato-thalamo-cortical loops, functional alterations in prefrontal and parietal regions, and dopamine dysregulation65,66,67,68. Based on possible shared brain mechanisms and behavioral association of fatigue and attentional impairment, Hanken et al., proposed attention as the signature of MS-related fatigue22. Recent recommended cognitive phenotypes of MS proposed by de Meo et al., is consistent with this idea as only patients with severe executive/attention phenotype had high level of fatigue compared to others69. Specific details and pathways through which fatigue and attentional deficits in MS interact with each other requires large effort by conducting more mechanistic studies, since the pathophysiology of either of them is not clearly known yet.
Cross-sectional nature of this study limited causal interpretations and assessment of attention, fatigue, and their relationship through time. Moreover, we excluded MS patients with different comorbidities and those who experienced recent clinical relapse. Also, DMDs of patients and their objective state of other cognitive functions (e.g., information processing speed through symbol digit modalities test, executive function through paced auditory serial additional test) or psychiatric health (e.g., depression screening through questionnaires) were not considered in the statistical analysis. Longitudinal studies recruiting MS patients of different phenotypes in all stages of disease that enroll in psychophysics tasks of different cognitive domains beside neuroimaging evaluation are warranted, to fill the gaps and answer remaining questions.
Data availability
The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Filippi, M. et al. Multiple sclerosis. Nat. Rev. Dis. Primers 4, 49 (2018).
DeLuca, J., Chiaravalloti, N. D. & Sandroff, B. M. Treatment and management of cognitive dysfunction in patients with multiple sclerosis. Nat. Rev. Neurol. 16, 319–332 (2020).
Kalb, R. et al. Recommendations for cognitive screening and management in multiple sclerosis care. Mult. Scler. J. 24, 1665–1680 (2018).
Carotenuto, A. et al. Cognitive trajectories in multiple sclerosis: A long-term follow-up study. Neurol. Sci. 43, 1215–1222 (2022).
Rosenstein, I. et al. High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis. Front. Immunol. 14, 1106028 (2023).
Williams, T. et al. Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial. Mult. Scler. 28, 1913–1926 (2022).
Kastner, S. The Oxford Handbook of Attention (Oxford University Press, 2014).
Poeppel, D., Mangun, G. R. & Gazzaniga, M. S. The Cognitive Neurosciences (The MIT Press, 2020).
Oreja-Guevara, C. et al. Cognitive dysfunctions and assessments in multiple sclerosis. Front. Neurol. 10, 1–9 (2019).
Arnett, P. A. & Strober, L. B. Cognitive and neurobehavioral features in multiple sclerosis. Expert Rev. Neurother. 11, 411–424 (2011).
Portaccio, E., De Meo, E., Bellinvia, A. & Amato, M. P. Cognitive issues in pediatric multiple sclerosis. Brain Sci. 11, 442 (2021).
Lanzillo, R. et al. Quality of life and cognitive functions in early onset multiple sclerosis. Eur. J. Paediatr. Neurol. 20, 158–163 (2016).
Krupp, L. B. et al. A new look at cognitive functioning in pediatric MS. Mult. Scler. 29, 140–149 (2023).
Brochet, B. et al. Cognitive impairment in secondary progressive multiple sclerosis: Effect of disease duration, age, and progressive phenotype. Brain Sci. 12, 183 (2022).
Roth, A. K., Denney, D. R. & Lynch, S. G. Information processing speed and attention in multiple sclerosis: Reconsidering the Attention Network Test (ANT). J. Clin. Exp. Neuropsychol. 37, 518–529 (2015).
Gonzalez-Rosa, J. J. et al. Differential cognitive impairment for diverse forms of multiple sclerosis. BMC Neurosci. 7, 1–11 (2006).
Guillemin, C. et al. The complex interplay between trait fatigue and cognition in multiple sclerosis. Psychol. Belg. 62, 108–122 (2022).
Spiegelberg, N. et al. Cognitive fatigue predicts cognitive failure in multiple sclerosis patients and healthy controls: A case-control study. Arch. Clin. Neuropsychol. 36, 908–917 (2021).
Rooney, S., Wood, L., Moffat, F. & Paul, L. Prevalence of fatigue and its association with clinical features in progressive and non-progressive forms of Multiple Sclerosis. Mult. Scler. Relat. Disord. 28, 276–282 (2019).
Sobczak, A. M. et al. Brain under fatigue—Can perceived fatigability in multiple sclerosis be seen on the level of functional brain network architecture?. Front. Hum. Neurosci. 16, 852981 (2022).
Walker, L. A. S., Berard, J. A., Berrigan, L. I., Rees, L. M. & Freedman, M. S. Detecting cognitive fatigue in multiple sclerosis: Method matters. J. Neurol. Sci. 316, 86–92 (2012).
Hanken, K., Eling, P. & Hildebrandt, H. Is there a cognitive signature for MS-related fatigue?. Mult. Scler. 21, 376–381 (2015).
Golan, D. et al. The impact of subjective cognitive fatigue and depression on cognitive function in patients with multiple sclerosis. Mult. Scler. 24, 196–204 (2018).
Manjaly, Z.-M. et al. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 90, 642–651 (2019).
Beatty, W. W. et al. Changes in neuropsychological test performance over the workday in multiple sclerosis. Clin. Neuropsychol. 17, 551–560 (2003).
Morrow, S., Weinstock-Guttman, B., Munschauer, F., Hojnacki, D. & Benedict, R. Subjective fatigue is not associated with cognitive impairment in multiple sclerosis: Cross-sectional and longitudinal analysis. Mult. Scler. J. 15, 998–1005 (2009).
Posner, M. I., Nissen, M. J. & Ogden, W. C. Attended and unattended processing modes: The role of set for spatial location. Modes of Perceiving and Processing Information 137–157. https://doi.org/10.1103/PhysRevLett.107.057601 (1978).
Gonzalez-Rosa, J. J. et al. Cluster analysis of behavioural and event-related potentials during a contingent negative variation paradigm in remitting-relapsing and benign forms of multiple sclerosis. BMC Neurol. 11, 64 (2011).
Fan, J., McCandliss, B. D., Sommer, T., Raz, A. & Posner, M. I. Testing the efficiency and independence of attentional networks. J. Cogn. Neurosci. 14, 340–347 (2002).
Urbanek, C. et al. Attention network test reveals alerting network dysfunction in multiple sclerosis. Mult. Scler. 16, 93–99 (2010).
Crivelli, L. et al. Alerting network dysfunction in early multiple sclerosis. J. Int. Neuropsychol. Soc. 18, 757–763 (2012).
Vaźquez-Marrufo, M. et al. Neural correlates of alerting and orienting impairment in multiple sclerosis patients. PLoS One 9, 1–10 (2014).
Wojtowicz, M. A., Ishigami, Y., Mazerolle, E. L. & Fisk, J. D. Stability of intraindividual variability as a marker of neurologic dysfunction in relapsing remitting multiple sclerosis. J. Clin. Exp. Neuropsychol. 36, 455–463 (2014).
Ishigami, Y., Fisk, J. D., Wojtowicz, M. & Klein, R. M. Repeated measurement of the attention components of patients with multiple sclerosis using the Attention Network Test-Interaction (ANT-I): Stability, isolability, robustness, and reliability. J. Neurosci. Methods 216, 1–9 (2013).
Roth, A. K., Denney, D. R. & Lynch, S. G. Information processing speed and attention in multiple sclerosis. J. Clin. Exp. Neuropsychol. 37, 518–529 (2015).
Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173 (2018).
Goodkin, D. E. & Hertsgaard, J. S. Upper extremity function in multiple sclerosis: Improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch. Phys. Med. Rehabil. 69, 850–854 (1988).
Wang, Y. C., Bohannon, R. W., Kapellusch, J., Garg, A. & Gershon, R. C. Dexterity as measured with the 9-Hole Peg Test (9-HPT) across the age span. J. Hand Ther. 28, 53–60 (2015).
Ghajarzadeh, M., Jalilian, R., Eskandari, G., Ali Sahraian, M. & Reza Azimi, A. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis. Disabil. Rehabil. 35, 1509–1512 (2013).
Badrkhahan, S. Z., Sikaroodi, H., Sharifi, F., Kouti, L. & Noroozian, M. Validity and reliability of the Persian version of the Montreal Cognitive Assessment (MoCA-P) scale among subjects with Parkinson’s disease. Appl. Neuropsycol. Adult. 27, 431–439. https://doi.org/10.1080/23279095.2019.1565762 (2019).
Posner, M. I. Orienting of attention. Q. J. Exp. Psychol. 32, 3–25 (1980).
Brainard, D. H. The Psychophysics Toolbox. Spat. Vis. 10, 433–436 (1997).
Serda, M. et al. What’s new in psychtoolbox-3. Perception 36, 1–16 (2007).
Lee, K. A., Hicks, G. & Nino-Murcia, G. Validity and reliability of a scale to assess fatigue. Psychiatry Res. 36, 291–298 (1991).
Carrasco, M. & Barbot, A. Spatial attention alters visual appearance. Curr. Opin. Psychol. 29, 56–64 (2019).
Carrasco, M. Visual attention: The past 25 years. Vis. Res. 51, 1484 (2011).
Chica, A. B., Bartolomeo, P. & Lupiáñez, J. Two cognitive and neural systems for endogenous and exogenous spatial attention. Behav. Brain Res. 237, 107–123 (2013).
Dugué, L., Merriam, E. P., Heeger, D. J. & Carrasco, M. Differential impact of endogenous and exogenous attention on activity in human visual cortex. Sci. Rep. 10, 21274 (2020).
Bowling, J. T., Friston, K. J. & Hopfinger, J. B. Top-down versus bottom-up attention differentially modulate frontal–parietal connectivity. Hum. Brain Mapp. 41, 928 (2020).
DeLuca, G. C., Yates, R. L., Beale, H. & Morrow, S. A. Cognitive impairment in multiple sclerosis: Clinical, radiologic and pathologic insights. Brain Pathol. 25, 79 (2015).
Cree, B. A. C. et al. Secondary progressive multiple sclerosis. Neurology 97, 378–388 (2021).
Spiegelberg, N. et al. Cognitive fatigue predicts cognitive failure in multiple sclerosis patients and healthy controls: A case–control study. Arch. Clin. Neuropsychol. 36, 908–917 (2021).
Yigit, P., Acikgoz, A., Mehdiyev, Z., Dayi, A. & Ozakbas, S. The relationship between cognition, depression, fatigue, and disability in patients with multiple sclerosis. Ir. J. Med. Sci. 190, 1129–1136 (2021).
Bellew, D. et al. Interpreting the clinical importance of the relationship between subjective fatigue and cognitive impairment in multiple sclerosis (MS): How BICAMS performance is affected by MS-related fatigue. Mult. Scler. Relat. Disord. 67, 104161 (2022).
Covey, T. J. et al. The relationship between cognitive impairment, cognitive fatigue, and visual evoked potential latency in people with multiple sclerosis. Mult. Scler. Relat. Disord. 57, 103349 (2022).
Ishii, A., Tanaka, M. & Watanabe, Y. Neural mechanisms of mental fatigue. Rev. Neurosci. 25, 469–479 (2014).
Sumowski, J. F. & Leavitt, V. M. Cognitive reserve in multiple sclerosis. Mult. Scler. J. 19, 1122–1127 (2013).
Holtzer, R., Shuman, M., Mahoney, J. R., Lipton, R. & Verghese, J. Cognitive fatigue defined in the context of attention networks. Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn. 18, 108–128 (2011).
Hou, R. et al. Attention processes in chronic fatigue syndrome: Attentional bias for health-related threat and the role of attentional control. Behav. Res. Ther. 52, 9–16 (2014).
Capone, F., Collorone, S., Cortese, R., Di Lazzaro, V. & Moccia, M. Fatigue in multiple sclerosis: The role of thalamus. Mult. Scler. 26, 6–16 (2020).
Chalah, M. A. & Ayache, S. S. Is there a link between inflammation and fatigue in multiple sclerosis?. J. Inflamm. Res. 11, 253–264 (2018).
Valdés Cabrera, D., Smyth, P., Blevins, G., Emery, D. & Beaulieu, C. Diffusion imaging of fornix and interconnected limbic deep grey matter is linked to cognitive impairment in multiple sclerosis. Eur. J. Neurosci. 55, 277–294 (2022).
Lin, F. et al. Altered nuclei-specific thalamic functional connectivity patterns in multiple sclerosis and their associations with fatigue and cognition. Mult. Scler. J. 25, 1243–1254 (2019).
Iancheva, D., Trenova, A., Mantarova, S. & Terziyski, K. Functional magnetic resonance imaging correlations between fatigue and cognitive performance in patients with relapsing remitting multiple sclerosis. Front. Psychiatry 10, 754 (2019).
Sarrias-Arrabal, E., Izquierdo-Ayuso, G. & Vázquez-Marrufo, M. Attentional networks in neurodegenerative diseases: Anatomical and functional evidence from the Attention Network Test. Neurologia https://doi.org/10.1016/J.NRLENG.2020.05.022 (2022).
Arm, J., Ribbons, K., Lechner-Scott, J. & Ramadan, S. Evaluation of MS related central fatigue using MR neuroimaging methods: Scoping review. J. Neurol. Sci. 400, 52–71 (2019).
Adibi, I. et al. Multiple sclerosis-related fatigue lacks a unified definition: A narrative review. J. Res. Med. Sci. 27, 24 (2022).
Amin, M. & Ontaneda, D. Thalamic injury and cognition in multiple sclerosis. Front. Neurol. 11, 623914 (2021).
de Meo, E. et al. Identifying the distinct cognitive phenotypes in multiple sclerosis. JAMA Neurol. 78, 1 (2021).
Acknowledgements
We sincerely thank Ali Motahharynia, Leila Sadat Razian, Maryam Mokhtari, and Zahra Mohamad Hoseiny for their cooperation in coordinating patients.
Funding
This study was funded by a startup grant to Center for Translational Neuroscience from Isfahan University of Medical Sciences.
Author information
Authors and Affiliations
Contributions
M.S. and I.A. made the conception of study and are the corresponding authors. F.T. and M.S. designed psychophysics tasks. V.S., F.A., and I.A. were the physicians of the patients and responsible for neurological data. F.T. and K.A. collected data. F.T. and M.S. performed statistical analyses. All the authors cooperated in writing drafts. M.S. and I.A. revised the final manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Tabibian, F., Azimzadeh, K., Shaygannejad, V. et al. Patterns of attention deficit in relapsing and progressive phenotypes of multiple sclerosis. Sci Rep 13, 13045 (2023). https://doi.org/10.1038/s41598-023-40327-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-023-40327-x
This article is cited by
-
Behavioral disorders in multiple sclerosis: a comprehensive review
Journal of Neural Transmission (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.